These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15018331)

  • 1. Prolactinoma with a high adrenocorticotropic hormone level caused by meningitis--case report.
    Utsuki S; Oka H; Tanaka S; Iwamoto K; Hasegawa H; Hirose R; Fujii K
    Neurol Med Chir (Tokyo); 2004 Feb; 44(2):86-9. PubMed ID: 15018331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sellar gangliocytoma with adrenocorticotropic and prolactin adenoma.
    Kissiedu JO; Prayson RA
    J Clin Neurosci; 2016 Feb; 24():141-2. PubMed ID: 26314658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Microsurgical Sublabial Approach (MSA) Versus Endoscopic Endonasal Approach (EEA) for the Treatment of Pituitary Adenomas Based on Radiological and Hormonal Outcome.
    Mattogno PP; Mangiola A; Lofrese G; Vigo V; Anile C
    Acta Neurochir Suppl; 2017; 124():101-106. PubMed ID: 28120060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sjögren's Syndrome Accompanied by Prolactinoma: a case report and literature review.
    Oh YJ; Lee WS; Yoo WH; Hahm JR; Kim HO; Suh YS; Lee SI; Cheon YH
    Int J Rheum Dis; 2017 Nov; 20(11):1823-1826. PubMed ID: 26355497
    [No Abstract]   [Full Text] [Related]  

  • 5. What causes a prolactinoma to be aggressive or to become a pituitary carcinoma?
    Phillips J; East HE; French SE; Melcescu E; Hamilton RD; Nicholas WC; Fratkin JF; Parent AD; Luzardo G; Koch CA
    Hormones (Athens); 2012; 11(4):477-82. PubMed ID: 23422771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired growth hormone secretion in patients operated for pituitary adenomas.
    Hoeck HC; Bang F; Laurberg P
    Growth Regul; 1994 Jun; 4(2):63-7. PubMed ID: 7950904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyper-adrenocorticotropinemia in a patient with Addison's disease after treatment with corticosteroids.
    Sugiyama K; Kimura M; Abe T; Ikezawa Y; Manaka H; Yamatani K; Tominaga M; Sasaki H; Misawa T
    Intern Med; 1996 Jul; 35(7):555-9. PubMed ID: 8842762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative correlation between tumour size and cortisol/ACTH ratios in patients with Cushing's disease harbouring microadenomas or macroadenomas.
    Machado MC; Alcantara AE; Pereira AC; Cescato VA; Castro Musolino NR; de Mendonça BB; Bronstein MD; Fragoso MC
    J Endocrinol Invest; 2016 Dec; 39(12):1401-1409. PubMed ID: 27363699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment for male prolactinoma: A retrospective study of 184 cases.
    Song YJ; Chen MT; Lian W; Xing B; Yao Y; Feng M; Wang RZ
    Medicine (Baltimore); 2017 Jan; 96(2):e5833. PubMed ID: 28079813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Giant pituitary prolactinoma with falsely low serum prolactin: the pitfall of the "high-dose hook effect": case report.
    Barkan AL; Chandler WF
    Neurosurgery; 1998 Apr; 42(4):913-5; discussion 915-6. PubMed ID: 9574657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plurihormonal ACTH-GH Pituitary Adenoma: Case Report and Systematic Literature Review.
    Roca E; Mattogno PP; Porcelli T; Poliani L; Belotti F; Schreiber A; Maffezzoni F; Fontanella MM; Doglietto F
    World Neurosurg; 2018 Jun; 114():e158-e164. PubMed ID: 29501516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined acromegaly and subclinical Cushing disease related to high-molecular-weight adrenocorticotropic hormone.
    Oki K; Yamane K; Oda Y; Kamei N; Watanabe H; Tominaga A; Amatya VJ; Oki Y; Kohno N
    J Neurosurg; 2009 Feb; 110(2):369-73. PubMed ID: 18991502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre- and post-operative hypothalamic-pituitary-thyroidal axis function in patients with prolactinoma, growth hormone tumour and ACTH tumour.
    Lu C; Lin XT; Yang DT; Liu YC; He WT; Zhong XL
    Chin Med J (Engl); 1989 Apr; 102(4):306-12. PubMed ID: 2551602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging measurements of pituitary stalk compression and deviation in patients with nonprolactin-secreting intrasellar and parasellar tumors: lack of correlation with serum prolactin levels.
    Smith MV; Laws ER
    Neurosurgery; 1994 May; 34(5):834-9; discussion 839. PubMed ID: 8052379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant Cushing's Disease and Marked Hyperprolactinemia: Response to a Dopamine Receptor Agonist.
    Shiraishi J; Koyama H; Shirakawa M; Ishikura R; Okazaki H; Kurajoh M; Shoji T; Moriwaki Y; Yamamoto T; Namba M
    Intern Med; 2016; 55(8):935-41. PubMed ID: 27086808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early morning cortisol levels as predictors of short-term and long-term adrenal function after endonasal transsphenoidal surgery for pituitary adenomas and Rathke's cleft cysts.
    McLaughlin N; Cohan P; Barnett P; Eisenberg A; Chaloner C; Kelly DF
    World Neurosurg; 2013 Nov; 80(5):569-75. PubMed ID: 22902358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity and hypercholesterolemia in patients with prolactinomas: Could DHEA-S and growth hormone be the missing link?
    Perić B; Kruljac I; Šundalić S; Pećina HI; Jović A; Štefanović M; Butorac D; Vrkljan M
    Endocr Res; 2016 Aug; 41(3):200-6. PubMed ID: 26864960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary prolactin-secreting tumor formation: recent developments.
    Xu RK; Wu XM; Di AK; Xu JN; Pang CS; Pang SF
    Biol Signals Recept; 2000; 9(1):1-20. PubMed ID: 10686432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin hypoglycemia test and releasing hormone (corticotropin-releasing hormone and growth hormone-releasing hormone) stimulation in patients with pituitary failure of different origin.
    Stalla GK; Losa M; Oeckler R; Müller OA; von Werder K
    Horm Res; 1988; 29(5-6):191-6. PubMed ID: 2851521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hormonal response to stress is not modified by the dramatic decrease in prolactin plasma concentration during surgery for microprolactinoma.
    Guieu R; Dufour H; Devaux C; Brue T; Rosso JP; Grisoli F; Grino M; Enjalbert A; Begoud D; Broder N; Rochat H; Jaquet P
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):502-7. PubMed ID: 9771773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.